Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
BACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.
| Published in: | Canadian Respiratory Journal |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2003-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2003/148740 |